• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMERIEUX SA VIDAS HCG; VIDAS® HCG

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMERIEUX SA VIDAS HCG; VIDAS® HCG Back to Search Results
Catalog Number 30405
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Patient Involvement (2645)
Event Type  malfunction  
Event Description
Note: reference 30405 is not registered in the united states.The u.S.Similar device is product reference 30405-01 a customer in germany notified biomérieux obtaining an out of range high results in association with the vidas® hcg 60 tests (ref 30405, lot 1007820580) when testing an instand eqa sample.The customer tested the sample in duplicate using lot 1007820580; the specified range and customer results are listed below: sample 32 - expected range = 36268 ¿ 67354 mui/ml result 1: 77709 mui/ml ¿ result is out of range high result 2: 73226 mui/ml ¿ result is out of range high the customer stated the sample was tested like a patient sample: with a dilution series of 1:10, then tested with a dilution equivalent to 1:100, using r1 diluent.Biomerieux requested the customer performed a qcv test; this information has not yet been provided.As there is no patient associated with this eqa strain, there is no adverse event related to any patient's state of health.Biomerieux has initiated an internal investigation.
 
Manufacturer Narrative
This report was initially submitted following notification from a customer in germany regarding an out-of-range-high result in association with the vidas® hcg 60 tests (ref (b)(4), lot 1007820580) when testing an instand eqa sample.The customer¿s samples were requested for the investigation; however, the samples were not available for submission.No anomalies were identified during the manufacturing, control, or packaging processes for vidas® hcg lot 1007820580/210102-0.The complaints laboratory analyzed the control chart results of six (6) internal samples with a target within the measurement range of vidas® hcg, on seven (7) different batches of vidas® hcg ref (b)(4) including the customer¿s lot 1007820580/210102-0.The analysis showed all results were within specifications, and the customer¿s lot was in trend of the other lots.Testing of internal samples with vidas® hcg 1007820580/210102-0 retain kit obtained results within specification.The results were similar compared to those obtained before the batch release.The complaint laboratory tested external quality control probioqual on retain kit vidas® hcg 1007820580/210102-0, and also obtained results within expected ranges.In the absence of the instand samples submission by the customer, it is impossible to pursue further investigations into the root cause of the customer¿s results.It was not possible to check if the dilution may have had an impact on the results.Biomérieux never received any information from instand regarding the behavior of the quality control samples after dilution.There is no reconsideration of the performance of vidas® hcg ref (b)(4), lot 1007820580/210102-0.See section h10.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VIDAS HCG
Type of Device
VIDAS® HCG
Manufacturer (Section D)
BIOMERIEUX SA
chemin de l orme
marcy l etoile 69280
FR  69280
MDR Report Key10997930
MDR Text Key222038456
Report Number8020790-2020-00133
Device Sequence Number1
Product Code DHA
Combination Product (y/n)N
PMA/PMN Number
K141133
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 01/26/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/02/2021
Device Catalogue Number30405
Device Lot Number1007820580
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 11/12/2020
Initial Date FDA Received12/13/2020
Supplement Dates Manufacturer Received01/05/2021
Supplement Dates FDA Received01/26/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-